OR WAIT null SECS
© 2023 MJH Life Sciences and BioPharm International. All rights reserved.
© 2023 MJH Life Sciences™ and BioPharm International. All rights reserved.
March 10, 2022
Curia and the US government have entered into a cooperative agreement to expand fill/finish capability for injectable medicines.
March 01, 2022
The continuous, aseptic fill/finish process is finding use in vaccines and biologic drugs.
February 23, 2022
Moderna and Thermo Fisher Scientific have formed a collaboration to leverage dedicated commercial fill/finish manufacturing capacity in the US for mRNA vaccines and therapies.
December 13, 2021
Fareva plans to use blow-fill-seal equipment and ApiJect’s prefilled injector technology to create fill/finish capacity in France.
November 01, 2021
Disposable equipment components find use in small-volume aseptic biopharmaceutical manufacturing.
October 29, 2021
Global CDMO, ten23 health, has acquired filling technology and drug product manufacturing expert, swissfillon, enhancing its integrated offering.
September 02, 2021
Alternative materials, as well as supply-chain planning, are essential to ensure a reliable supply for parenteral drug packaging.
August 25, 2021
Lonza plans to establish drug product manufacturing capabilities at is site in Guangzhou, China, to produce clinical trial and commercial supply in the country.
August 01, 2021
Scenario modeling informs planning for current and future manufacturing needs.
June 30, 2021
Amgen’s greenfield facility near Columbus, Ohio to assemble and package vials and syringes is expected to be operational by 2024.